Insomnia News and Research

Latest Insomnia News and Research

Poor sleep during pregnancy can disrupt immune processes and lead to lower birth weights

Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and lead to lower birth weights and other complications, finds a University of Pittsburgh School of Medicine study published today in the journal Psychosomatic Medicine. Women with depression also are more likely than non-depressed women to suffer from disturbed sleep and to experience immune system disruption and adverse pregnancy outcomes.

18 Jul 2013

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully-integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that, through a wholly-owned subsidiary, the company entered into an agreement to acquire Talon Therapeutics, Inc., a biopharmaceutical company based in South San Francisco, California, and expects to complete the acquisition within one day.

17 Jul 2013

Drexel University receives NIH grant to study medical marijuana use among LA young adults

Drexel University has received a grant for a five-year study of medical marijuana and its impact on drug use and physical and psychological health among young adults in Los Angeles. It is the first large-scale NIH project funded to directly investigate medical marijuana use among young adults aged 18 to 26.

15 Jul 2013

Study examines whether better sleep lowers risk of heart disease

The University of South Florida College of Nursing is conducting research to improve sleep in those caring for people with dementia and Alzheimer's disease, with the aim of determining if better sleep affects heart health.

10 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

Merck, known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application for suvorexant, Merck's investigational medicine for the treatment of insomnia.

2 Jul 2013

Pre-deployment insomnia symptoms associated with major mental disorders

A new study from the Perelman School of Medicine at the University of Pennsylvania and the Naval Health Research Center has shown Military service members who have trouble sleeping prior to deployments may be at greater risk of developing posttraumatic stress disorder (PTSD), depression and anxiety once they return home.

30 Jun 2013

Study shows that individuals with SAD misreport sleep patterns due to depression

Lying awake in bed plagues everyone occasionally, but for those with seasonal affective disorder, sleeplessness is routine. University of Pittsburgh researchers report in the Journal of Affective Disorders that individuals with seasonal affective disorder -a winter depression that leads to loss of motivation and interest in daily activities-have misconceptions about their sleep habits similar to those of insomniacs.

28 Jun 2013

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

The US Food and Drug Administration has expanded the approved indication for Exelon Patch (rivastigmine transdermal system) to include the treatment of people with severe Alzheimer's disease with Exelon Patch 13.3mg/24h.

28 Jun 2013

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

24 Jun 2013

Research: Sleep mechanism enables brain to consolidate emotional memory

Sleep researchers from University of California campuses in Riverside and San Diego have identified the sleep mechanism that enables the brain to consolidate emotional memory and found that a popular prescription sleep aid heightens the recollection of and response to negative memories.

13 Jun 2013

Common medications reduce brain plaques in mice

Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings are published online in the journal PLoS One.

13 Jun 2013

Binge drinking more than 2 days per week is associated with insomnia symptoms

A new study suggests that frequent binge drinking is associated with insomnia symptoms in older adults.

11 Jun 2013

Review on new, hazardous drugs of abuse presented in Journal of Addiction Medicine

The last few years have seen the emergence of a new drug problem in so-called "bath salts"-actually "designer stimulants," packaged and sold in ways that skirt drug laws. A review and update on these designer drugs is presented in the June Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

5 Jun 2013

People with narcolepsy have increased number of neurons that produce histamine

A new study provides surprising evidence that people with narcolepsy have an increased number of neurons that produce histamine, suggesting that histamine signaling may be a novel therapeutic target for this potentially disabling sleep disorder.

4 Jun 2013

Study demonstrates link between workplace daylight exposure to sleep, quality of life

A new study demonstrates a strong relationship between workplace daylight exposure and office workers' sleep, activity and quality of life.

4 Jun 2013

Sleep deprivation increases men's perceptions of women's interest in sex

A new study suggests that one night of sleep deprivation leads to an increase in men's perceptions of both women's interest in and intent to have sex.

1 Jun 2013

Study suggests bright light therapy may improve sleep and brain function post mild TBI

A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).

1 Jun 2013

Study shows that 23% of North Sea workers suffer from shift work disorder

Some workers in Norway's North Sea Oil industry alternate between night and day shifts, the so-called swing shift. A recent study conducted by Postdoctoral fellow Siri Waage and colleagues at the University of Bergen's Department of Global Public Health and Primary Care, shows that sleep quality and complaints of insomnia became worse during the offshore work period amongst both these swing shift workers and those who only do day shifts.

1 Jun 2013

Fatigue and sleep have predictive value for sports performance

Two new studies show that fatigue may impair strike-zone judgment during the 162 game Major League Baseball season, and a MLB player's sleepiness can predict his longevity in the league.

1 Jun 2013

Insomnia News and Research

Latest Insomnia News and Research

Poor sleep during pregnancy can disrupt immune processes and lead to lower birth weights

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Drexel University receives NIH grant to study medical marijuana use among LA young adults

Study examines whether better sleep lowers risk of heart disease

Soligenix announces personalized medicine collaboration with SciClone

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

Pre-deployment insomnia symptoms associated with major mental disorders

Study shows that individuals with SAD misreport sleep patterns due to depression

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Research: Sleep mechanism enables brain to consolidate emotional memory

Common medications reduce brain plaques in mice

Binge drinking more than 2 days per week is associated with insomnia symptoms

Review on new, hazardous drugs of abuse presented in Journal of Addiction Medicine

People with narcolepsy have increased number of neurons that produce histamine

Study demonstrates link between workplace daylight exposure to sleep, quality of life

Sleep deprivation increases men's perceptions of women's interest in sex

Study suggests bright light therapy may improve sleep and brain function post mild TBI

Study shows that 23% of North Sea workers suffer from shift work disorder

Fatigue and sleep have predictive value for sports performance

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Insomnia News and Research

Latest Insomnia News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in